🕵️ Latigo Biotherapeutics, Inc. ($LTGO)
SEC insider & ownership activity, last 12 months · CIK 2056611 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
Insider flow
2 buyers, value withheld pending verification (2 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| James B. Tananbaum | 1 | value withheld pending verification | 0 | – | Aug 10, 2026 |
| Foresite Capital Management V, LLC | 1 | value withheld pending verification | 0 | – | Aug 10, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| James B. Tananbaum | 14.5% | 13D | Aug 10, 2026 | filing ↗ | |
| RA Capital Management, L.P. | 8.4% | 13G | Aug 17, 2026 | filing ↗ | |
| Peter Kolchinsky | 8.4% | 13G | Aug 17, 2026 | filing ↗ | |
| Rajeev Shah | 8.4% | 13G | Aug 17, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 8.4% | 13G | Aug 17, 2026 | filing ↗ | |
| DEEP Track Capital, LP | 7.0% | 13G | Aug 13, 2026 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 7.0% | 13G | Aug 13, 2026 | filing ↗ | |
| David Kroin | 7.0% | 13G | Aug 13, 2026 | filing ↗ | |
| Foresite Capital Fund V, L.P. | 5.6% | 13D | Aug 10, 2026 | filing ↗ | |
| Foresite Capital Management V, LLC | 5.6% | 13D | Aug 10, 2026 | filing ↗ | |
| Foresite Capital Opportunity Fund V, L.P. | 5.4% | 13D | Aug 10, 2026 | filing ↗ | |
| Foresite Capital Opportunity Management V, LLC | 5.4% | 13D | Aug 10, 2026 | filing ↗ | |
| AI Biotechnology LLC | 5.0% | 13G | Aug 18, 2026 | filing ↗ | |
| Access Industries Holdings LLC | 5.0% | 13G | Aug 18, 2026 | filing ↗ | |
| Access Industries Management, LLC | 5.0% | 13G | Aug 18, 2026 | filing ↗ | |
| Len Blavatnik | 5.0% | 13G | Aug 18, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Sep 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 3, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Aug 10, 2026 | filing ↗ |
| Other events (8.01) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |